🇺🇸 FDA

Company profile · Sponsor

Biodexa

Biodexa Pharmaceuticals Plc

BDRX · NYSE pharma CARDIFF, USA
Pipeline
4
Drugs
0
Patents
2

Quick answer

Biodexa (BDRX) is a pharma company. headquartered in CARDIFF, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 2 patents to this profile..

Company facts

Ticker BDRX
Exchange NYSE
Company type pharma
Headquarters CARDIFF, USA
SEC CIK 0001643918

Pipeline (4)

Search pipeline →

  1. White opaque capsule filled with a white to off- white powder, eRapa

    Biodexa

    Familial adenomatous polyposis (FAP)

    phase 3 small molecule active

    1 trial

  2. eRapa (encapsulated rapamycin)

    Biodexa

    Familial Adenomatous Polyposis (FAP)

    phase 3 small molecule active

    1 trial

  3. Encapsulated Rapamycin (eRapa)

    Biodexa

    Familial Adenomatous Polyposis

    phase 2 small molecule active

    1 trial

  4. MTX110

    Biodexa

    Recurrent Glioblastoma

    phase 1 small molecule terminated

    1 trial

Patents (2)

Search patents →

  1. US 7101863

    Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative

    Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 6646120

    Dextran derivatives, preparation and medicinal applications

    Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is Biodexa?

Biodexa (BDRX) is a pharma company. headquartered in CARDIFF, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 2 patents to this profile..

What pipeline programs does Biodexa sponsor?

We track 4 ClinicalTrials.gov-linked programs for Biodexa, including White opaque capsule filled with a white to off- white powder, eRapa and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Biodexa company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.